Editorial: Is there a link between a high-fat diet during puberty and breast cancer risk?

Women's Health

Volumn 7, Issue 1, 2011, Pages 1-3

  Haslam, Sandra Z ^a   Schwartz, Richard C ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

breast cancer; high fat diet; puberty

Indexed keywords

ANTIINFLAMMATORY AGENT; ESTROGEN; GESTAGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PALMITIC ACID; PROGESTERONE; SATURATED FATTY ACID; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; ESTROGEN BLOOD LEVEL; GENETIC VARIABILITY; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; IMMUNE DYSREGULATION; INFLAMMATORY DISEASE; INSULIN RESISTANCE; LIPID DIET; METASTASIS; NONHUMAN; OBESITY; POSTMENOPAUSE; PUBERTY; RISK ASSESSMENT; RISK REDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BODY MASS; BREAST; BREAST TUMOR; DISEASE MODEL; FAT INTAKE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; RISK FACTOR; TIME;

ANIMALS; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; OBESITY; PUBERTY; RISK FACTORS; TIME;

EID: 78650644913     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.83     Document Type: Editorial

References (25)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13), 1549-1555 (2006).
2. Catenacci VA, Hill JO, Wyatt HR: The obesity epidemic. Clin. Chest Med. 30(3), 415-444 (2009).
3. Kaplowitz PB: Link between body fat and the timing of puberty. Pediatrics 121(Suppl. 3), S208-S217 (2008).
4. Golub MS, Collman GW, Foster PM et al.: Public health implications of altered puberty timing. Pediatrics 121(Suppl. 3), S218-S230 (2008).
5. Biro FM: Body morphology and its impact on adolescent and pediatric gynecology, with a special emphasis on polycystic ovary syndrome. Curr. Opin. Obstet. Gynecol. 15(5), 347-351 (2003).
6. Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ: Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin. Breast Cancer 8(4), 334-342 (2008).
7. Khalid S, Hwang D, Babichev Y et al.: Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Res. Treat. 122(3), 647-659 (2010).
8. Nunez NP, Oh WJ, Rozenberg J et al.: Accelerated tumor formation in a fatless mouse with Type 2 diabetes and inflammation. Cancer Res. 66(10), 5469-5476 (2006).
9. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, Cleary MP: Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-a mice. Breast Cancer Res. 9(6), R91 (2007).
10. Sieri S, Krogh V, Ferrari P et al.: Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 88(5), 1304-1312 (2008).
11. Pischon T, Nothlings U, Boeing H: Obesity and cancer. Proc. Nutr. Soc. 67(2), 128-145 (2008).
12. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ: Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J. Clin. Endocrinol. Metab. 84(12), 4559-4565 (1999).
13. Aupperlee MD, Haslam SZ: Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 148(5), 2290-2300 (2007).
14. Aupperlee MD, Drolet AA, Durairaj S, Wang W, Schwartz RC, Haslam SZ: Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. Endocrinology 150(3), 1485-1494 (2009).
15. Rossouw JE, Anderson GL, Prentice RL et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial. JAMA 288(3), 321-333 (2002).
16. Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res. Treat. 107(3), 427-430 (2008).
17. Santos SJ, Aupperlee MD, Xie J et al.: Progesterone receptor A-regulated gene expression in mammary organoid cultures. J. Steroid Biochem. Mol. Biol. 115(3-5), 161-172 (2009).
18. Pollard JW: Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 84(3), 623-630 (2008).
19. Suganami T, Tanimoto-Koyama K, Nishida J et al.: Role of the Toll-like receptor 4/NF-kB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27(1), 84-91 (2007).
20. Ajuwon KM, Spurlock ME: Palmitate activates the NF-kB transcription factor and induces IL-6 and TNFa expression in 3T3-L1 adipocytes. J. Nutr. 135(8), 1841-1846 (2005).
21. Magne J, Mariotti F, Fischer R, Mathe V, Tome D, Huneau JF: Early postprandial low-grade inflammation after high-fat meal in healthy rats: possible involvement of visceral adipose tissue. J. Nutr. Biochem. 21(6), 550-555 (2009).
22. Erridge C, Attina T, Spickett CM, Webb DJ: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86(5), 1286-1292 (2007).
23. Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B: Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am. J. Epidemiol. 166(6), 709-716 (2007).
24. Harris RE, Alshafie GA, Abou-Issa H, Seibert K: Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 60(8), 2101-2103 (2000).
25. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ: Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int. J. Obes. (Lond.) 34(9), 1415-1426 (2010).